Xiaoxi Yang Selected Research

Xiaoxi Yang Research Topics

Disease

11	Neoplasms (Cancer) 10/2022 - 01/2013
5	Inflammation (Inflammations) 07/2022 - 10/2017
2	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2022 - 03/2021
2	Insulin Resistance 01/2022 - 02/2020
2	Obesity 01/2022 - 11/2019
2	Cicatrix (Scar) 11/2021 - 04/2018
2	Body Weight (Weight, Body) 02/2020 - 03/2016
2	Carcinogenesis 11/2019 - 09/2019
2	Kyphosis 05/2019 - 01/2017
2	Pterygium 01/2019 - 03/2010
2	Breast Neoplasms (Breast Cancer) 08/2018 - 01/2014
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2016 - 06/2015
1	Fatty Liver 11/2022
1	Degloving Injuries 06/2022
1	End Stage Liver Disease 06/2022
1	Coronavirus Infections 01/2022
1	Abdominal Obesity 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Alopecia (Baldness) 11/2021
1	Arthritis (Polyarthritis) 10/2021
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Thromboembolism 01/2021
1	Hypertrophy 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2020
1	Neoplasm Metastasis (Metastasis) 08/2020
1	Uveal melanoma 11/2019
1	Teratoma (Teratoid Tumor) 09/2019
1	Ankylosing Spondylitis 05/2019
1	Retinoblastoma (Glioblastoma, Retinal) 01/2019
1	Pericardial Effusion 05/2018
1	Left Ventricular Dysfunction 04/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2017
1	Carcinoma (Carcinomatosis) 06/2017
1	Osteosarcoma (Osteogenic Sarcoma) 03/2017
1	Myocardial Infarction 01/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
3	Biological ProductsIBA 01/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2019
2	Sirtuin 1IBA 11/2022 - 05/2022
2	Long Noncoding RNAIBA 05/2022 - 01/2019
2	LipidsIBA 01/2022 - 02/2020
2	3-tert-butyl-4-hydroxyanisoleIBA 01/2022 - 02/2020
2	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 02/2020
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2015 - 01/2014
2	Telomere-Binding ProteinsIBA 01/2014 - 01/2013
1	Transcription Factors (Transcription Factor)IBA 10/2022
1	ElementsIBA 07/2022
1	CreatinineIBA 06/2022
1	Prothrombin (Factor II)IBA 06/2022
1	6-methyladenineIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	MicroplasticsIBA 01/2022
1	Polystyrenes (Polystyrene)IBA 01/2022
1	Virus ReceptorsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021
1	AutoantibodiesIBA 10/2021
1	Rosiglitazone (Avandia)FDA Link 03/2021
1	semaglutideIBA 03/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	CytokinesIBA 11/2020
1	Protein Kinases (Protein Kinase)IBA 08/2020
1	Actin Depolymerizing Factors (Cofilins)IBA 08/2020
1	GoldIBA 08/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Sincalide FDA Link 11/2019
1	LuciferasesIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Butylated Hydroxyanisole (BHA)IBA 11/2019
1	Food Additives (Food Additive)IBA 11/2019
1	Polychlorinated Dibenzodioxins (TCDD)IBA 09/2019
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 09/2019
1	Sunitinib (Sutent)FDA Link 01/2019
1	IodineIBA 08/2018
1	IodidesIBA 08/2018
1	AlkanesIBA 08/2018
1	Protein Isoforms (Isoforms)IBA 08/2018
1	Estrogen Receptor alphaIBA 08/2018
1	Rheumatoid FactorIBA 05/2018
1	N 30IBA 04/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017
1	Protein Kinase CIBA 06/2017
1	Small Interfering RNA (siRNA)IBA 06/2017
1	sotrastaurinIBA 06/2017
1	NF-kappa B (NF-kB)IBA 06/2017
1	Transcription Factor RelAIBA 06/2017
1	MagnesiumIBA 03/2017
1	AlloysIBA 03/2017
1	SilverIBA 03/2016

Therapy/Procedure

4	Therapeutics 01/2022 - 06/2015
2	Osteotomy 05/2019 - 01/2017
1	Surgical Amputation (Amputations) 06/2022
1	Replantation 06/2022
1	Oral Administration 01/2022
1	Transplantation 09/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017